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Abstract: The deterministic sequence→ structure→ function relationship is not applicable to describe
how proteins dynamically adapt to different cellular conditions. A stochastic model is required to
capture functional promiscuity, redundant sequence motifs, dynamic interactions, or conformational
heterogeneity, which facilitate the decision-making in regulatory processes, ranging from enzymes
to membraneless cellular compartments. The fuzzy set theory offers a quantitative framework to
address these problems. The fuzzy formalism allows the simultaneous involvement of proteins in
multiple activities, the degree of which is given by the corresponding memberships. Adaptation
is described via a fuzzy inference system, which relates heterogeneous conformational ensembles
to different biological activities. Sequence redundancies (e.g., tandem motifs) can also be treated
by fuzzy sets to characterize structural transitions affecting the heterogeneous interaction patterns
(e.g., pathological fibrillization of stress granules). The proposed framework can provide quantitative
protein models, under stochastic cellular conditions.
Keywords: protein dynamics; conformational heterogeneity; promiscuity; fuzzy complexes;
higher-order structures; protein evolution; fuzzy set theory; artificial intelligence
1. The Structure-Function Paradigm
Protein functions take place in space and time. Structure-function principles, however, relate a
protein sequence to biological activity, only via the spatial coordinates of the residues [1,2]:
SEQUENCE → STRUCTURE → FUNCTION
(x,y,z) (x,y,z,t)
(1)
The three-dimensional organization of amino acids brings different chemical groups into
proximity [3,4], creating specific microenvironments for biological activities. The emerging active
sites, for example, can catalyze chemical reactions at significantly faster rates, than in solution [5,6].
The classical, deterministic Paradigm 1 establishes an unambiguous connection between the protein
sequence and its function, via a unique structure.
2. The Ensemble View
The energy landscapes of proteins are, in reality, more complicated. Proteins fluctuate among
various conformations (‘macrostates’) and sub-states (‘microstates’), which need to be considered
for their relevant functioning [7–9]. A wide spectrum of dynamical transitions [10,11]—from local
movements (e.g., sidechain rotations [12]) to large-amplitude collective motions (e.g., domain
repositioning [13])—generates conformational ensembles, which, however, are not trivial to link
to the function. How can structure-function relationships account for protein dynamics? If protein
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structure is described as an ensemble, the populations of the relevant sub-states, as well as the rate of
interconversion between them, must be experimentally determined for each biological activity.
SEQUENCE → CONFORMATIONAL ENSEMBLE → FUNCTION
{pcs1 , . . . ,pcsN } (x,y,z,t)
{kcs1 , . . . ,kcsN }
(2)
where pCSi is the probability of the given conformational sub-state CSi, N is the number of sub-states,
and {kCSi } is the set of rates, corresponding to the conversions between CSi→CSj, where j corresponds
to all the other sub-states. Even if the number of conformational states is reduced to a few functionally
relevant ones, characterizing both their thermodynamic and kinetic properties is a daunting task [14,15].
Furthermore, the deterministic relationship between the ensemble parameters and a unique function
is also influenced by the environmental conditions.
3. Adaptation to Stochastic Cellular Conditions
Proteins function under rapidly changing extracellular signals and intracellular milieu, which
is shaped by cellular diffusion and transport, stochastic gene expression, degradation, and other
environmental fluctuations. These factors present stochastic conditions for protein evolution [16–18]
leading to ‘noise’ in biological innovations [19], which is reflected by redundancies and ambiguities
in sequences [20], structures [21], and functions [22]. On the one hand, proteins attempt to minimize
functional noise. For example, higher-order structures emerge to reduce noise-to-signal ratio for
low-affinity substrates [23–25]. On the other hand, ambiguities and redundancies in sequence, structure
and function facilitate dynamic adaptation [26]. Proteins evolve under these two opposing constraints
to optimize fitness under given cellular conditions.
4. Ambiguity and Redundancy in Sequence, Structure, and Function
The re-formatted paradigm (2), still implies that a given sequence generates a well-defined
ensemble, which belongs to a specific function. The stochastic cellular conditions lead to the following
observations, which violate the classical paradigm: (i) A considerable proportion of proteins exhibit
multiple, simultaneous activities, often referred to as promiscuity or moonlighting [27]. (ii) Certain
biological activities (i.e., signaling) are related to heterogeneous conformational ensembles, which are
mixtures of different functional ensembles [28]. (iii) Some proteins exhibit a weak sequence dependence,
i.e., a large degree of tolerance towards sequence modifications [29]. These observations stem from
redundancies in sequence or structure, coupled to ambiguities in function. The same ensemble may
perform multiple functions (functional promiscuity); the same sequence may be organized into multiple
functional ensembles, depending on the context (conformation and interaction heterogeneity); and multiple
sequences may encode the same conformational ensemble (sequence redundancy). These problems,
which reflect a more complex relationship between the sequence, structure, and function of proteins,
are detailed below.
5. Functional Promiscuity
Metabolic enzymes often catalyze reactions on the non-canonical substrates, some of which are
also relevant physiologically [27,30,31]. Functional promiscuity may parallel organism complexity [32],
or be driven by network context [33]. Promiscuous activities can serve as starting points to engineer
new enzymes [34]. Tailored selection pressures may optimize latent activities to overcome the
primary function by >109-fold [35]. Functional transitions are usually initiated by ‘neutral drifts’,
with a negligible impact on the original activity [36,37]. That is, the optimization of a promiscuous
function initially exploits the inherent variations in structure [38] and dynamics [39]. Functional
transition of a phosphotriesterase to arylesterase [35], for example, is coupled to increasing structural
divergence between the two subunits, until the two activities become comparable (Figure 1A).
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In contrast, specialization for the new activity is accompanied by structural convergence (Figure 1A).
Similarly, ‘freezing’ out unnecessary motions offers another route to optimize enzymatic efficiency [6].
Along these lines, principal modes derived from structure [40] often presage or follow the evolutionary
changes [41,42].
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Figure 1. Towards a stochastic structure-function relationship. (A) Structural diversity increases with
functional promiscuity. The distance between the L5 (lime, green) and L7 (wheat, orange) loops (A204
C–G273 C) deviates in the two subunits (superimposed) of a dimeric phosphotriesterase (PTE) enzyme
(PDB code: 4xag [39]). During laboratory evolution into arylesterase, the structural difference increases
as the two activities become comparable (R1→ R6), while it decreases during specialization (R8→ R22).
(B) Free energy landscape changes upon adaptation of proteins. Functional alterations shift the
relative populations of conformational sub-states, but may not impact the ruggedness of the landscape.
(C) Conformational sub-states (CSs) contribute to multiple free landscapes. The functional noise
(uncertainty of F1, F2, F3) of the main activity (bold) can be quantified by fuzzy membership functions.
(D) The fuzzy structure-function model. In the fuzzy inference system, the logical relationship is
established between the fuzzy sets of the input and output (top). In proteins, fuzzification generates
sets of interaction patterns amongst functional sequence motifs, which can be linked to conformational
sub-states. The connection between structure and function is a knowledge-based logical rule between
the set of conformational sub-states and the set of alternative functions, from which the most likely
activity can be selected (bottom).
6. Conformational Heterogeneity
Dynamic signals perturb conformational ensembles by changing the relative populations of the
different sub-states [43] (Figure 1B). The co-existence of functionally different conformations, in a
broad regime, may enable the same protein to be simultaneously engaged in multiple pathways [44].
An agonist binding to a β2-adrenergic receptor, for example, does not stabilize the active conformation
of the cytoplasmic domain; it rather increases the conformational heterogeneity of the active,
intermediate, and inactive states, for the complex signaling outputs [28].
Intriguing observations indicate that specific biomolecular recognition can also be achieved in
heterogeneous conformational ensembles [45–47]. Although the underlying molecular forces are often
puzzling [48,49], conformational ambiguities often enable context-dependent responses, via alternative
interaction patterns [50,51]. Conformational heterogeneity along the binding trajectory, has recently
been concluded to critically influence the structures in a complex, with different partners [52,53].
Structural ambiguities might even be a pre-requisite, for example, for efficient transcription [54] via a
fuzzy ‘free-for-all’ mechanism [55].
Conformational heterogeneity often leads to dynamic interaction profiles, where the functional
output (specificity, signal, and polymerization) is controlled by transient contacts [56,57]. Dynamic
interactions may also balance between the auto-inhibited and active states [58,59] and can be
significantly influenced by post-translational modifications (PTMs) [60,61]. Although the modification
pattern inducing the functional response can be defined, its impact on the underlying heterogeneous
conformational ensembles often remains unclear.
7. Redundant Sequence Motifs
Multiple, weakly-restrained sequence motifs are frequently distinguished in signaling pathways,
via mediating protein interactions [62]. Regions linking the motifs exhibit increased conformational
plasticity and reduced sensitivity to mutations or scrambling [63], leading to a phenomenon,
often referred to as ‘sequence independence’ [64]. Tandem repeats of a few residues, for example,
are often involved in the organization of higher-order structures [65], ranging from amyloids to
signaling complexes and nuclear pores [66]. Motif redundancy leads to the redundancy of interaction
patterns and the co-existence of different contact topologies. Although the interactions of the individual
motifs are often sub-optimal, their cooperativity may result in high-affinity associations [25,67].
Both the dynamics of the motif-linking regions, and the variations in contact patterns, lead to
conformational heterogeneity in higher-order assemblies [68]. The Fused in Sarcoma (Fus) protein,
for example, is involved in the formation of stress granules, via a liquid–liquid phase transition,
which is driven by its low-complexity (LC) domain, composed of 27 [S/G]Y[S/G] repeats. The NMR
spectra of the LC domain in the droplet, is similar to that of the unbound state, witnessing
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conformational heterogeneity in the assembly [69]. Single-point mutations may gradually decrease
conformational heterogeneity, leading to pathological aggregation [70]. Additional studies corroborate
the finding that pathological mutations initially induce minor perturbations [71], which simultaneously
affect multiple conformations/interaction patterns and induce their shift towards the fibril form.
8. Generalized Structure-Function Ensembles
The experimental data summarized in the above three sections are difficult to interpret via the
classical structure-function paradigm (2). We may attempt to solve these problems by treating the
sequences, conformations, and functions as generalized ensembles:
SEQUENCE (µ, σ) →CONFORMATIONAL ENSEMBLE (µ, σ) →FUNCTION (µ, σ) (3)
where µ is the mean, and σ is the variance of the respective distribution.
Evaluating the structure-function paradigm in the form (3), requires decoupling of all
the respective activities, to analyze the underlying distributions of conformational ensembles
and sequences. Careful experimental studies, along these lines [72], demonstrate that these
approaches are hardly feasible. First, because the dimensionality of the problem is overwhelming,
and second, the deconvolution of different functionalities may not be possible in vivo, owing to the
intricate connections.
9. Fuzzy Sets Quantify Sequence and Conformation Ambiguities
I propose that the fuzzy set theory [73] offers a quantitative framework to derive stochastic
structure-function relationships. In fuzzy sets U = {x1, x2, ..., xN } a membership function
m(xi) → [0, 1] ; xi ∈ U is assigned to each element, which characterizes to what extent xi belongs to
the given set. For example, the membership of a protein conformational sub-state (CSi), in a specific
functional set (F1), can vary between 0 and 1 (m1(CSi) : F1 → [0, 1] ), allowing the conformation to
contribute to additional activities (e.g., F2 and F3, Figure 1C). Memberships for other possible biological
functions could also be defined, using this formalism (Figure 1C). In a similar manner, memberships
of sequences in given conformational ensembles, (m1(SEQi) : CS1 → [0, 1] ), or in given functions
(m1(SEQi) : F1 → [0, 1] ), could also be quantified.
The structure-function paradigm could thus, be reformulated by treating the sequences and
conformational ensembles as fuzzy sets:
SEQUENCE → CONFORMATIONAL ENSEMBLE → FUNCTION (4)
mi(PI) : CSi → [0, 1] mi(CS) : Fi → [0, 1]
mi(PI) : Fi → [0, 1]
where mi(PI) is the respective membership function of a sequence, defined with respect to the
conformational states (CSi) or biological activity (Fi), as a pattern of interacting elements/motifs (PI).
mi(CS) is the membership function of the conformational sub-state/ensemble (CS), in a given function.
Here sequence, structure, and function are considered as different co-existing distributions
(Figure 1C), and their contributions change according to the cellular conditions. For example,
in the case of a β2-adrenergic receptor, the active, intermediate, and inactive states (represented
by three ensembles) are mixed differently, depending on the signaling input. The fuzzy formalism
handles combinations of activities aiming to determine the individual contributions of the different
conformational ensembles.
10. The Stochastic Structure-Function Relationship
Within this framework, the structure-function relationship can be quantified by a fuzzy
inference system [74,75] (Figure 1D). Parameters describing the elements of the sequence (motifs) or
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conformational space (distinguished secondary structures) are used as the input, and the different
biological activities serve as the output of the system. The first step is the fuzzification of the input,
when the fuzzy sets and their membership functions are defined to describe the interaction patterns,
and the corresponding conformational sub-states (Figure 1D). The fuzzy inputs are then combined and
knowledge-based logical rules (‘IF-THEN’) are applied to obtain the output membership functions of
the different biological activities in the system. These rules could be derived using machine-learning
or neural network algorithms. Defuzzification of the output can select the most likely activity, under a
given condition, while also accounting for other, promiscuous activities (Figure 1D).
The fuzzy model quantifies the functional ambiguities of the conformational sub-states:
∆Fmain = (
n
∑
i
δFi,main )/n (5)
where n is the number of alternative (promiscuous) activities, and Fmain is the main function with
membership function mmax. The contribution of function Fi, with respect to the main function,
is computed from the corresponding membership functions: δFi, main = mi/ mmax.
Here, the challenge is to define the membership functions. To this end, the efficiencies of the
alternative activities (e.g., catalytic rates) are determined via functional assays on well-characterized
conformations (e.g., crystal structures, chip-bound proteins, or those selected by conformational
antibodies) or ensembles (solution techniques, NMR, FRET, and single-molecule methods). Different
membership functions could be probed computationally, based on the regulatory characteristics (e.g.,
changing an auto-inhibited to an active state).
The fuzzy formalism (4) is particularly useful to relate the sequence sets to function.
Here structural features, which could be predicted from the sequence (e.g., secondary structure
elements, disordered regions, or post-translational modification sites) may serve to generate the
pattern of interaction elements (PI), to define the fuzzy sets. This approach has been implemented in
simulations of higher-order protein organizations [76].
11. Conclusion and Outlook
Proteins deal with uncertain information, regarding cellular conditions. The information is not
only imprecise, but various components are unknown or are unpredictable, owing to the non-random
fluctuations in the system. The functional characteristics of proteins need to be adjusted to this
poorly defined environment. The classical models in protein science, such as the structure-function
paradigm, are based on well-defined properties and cannot deal with the ambiguities related to “noise”.
The fuzzy set theory offers a quantitative framework to reformulate the structure-function paradigm
for describing the stochastic cellular behavior of proteins (Figure 1D). This approach will provide a
more holistic protein model, which can be applied to generate interaction or metabolic networks of
different cell lines as well as more reliable pharmacophore models.
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